DK163238C - 3-(1h-tetrazol-5-yl)-2(1h)-quinolinon samt farmaceutisk acceptable salte deraf og fremgangsmaade til fremstilling af disse forbindelser - Google Patents
3-(1h-tetrazol-5-yl)-2(1h)-quinolinon samt farmaceutisk acceptable salte deraf og fremgangsmaade til fremstilling af disse forbindelserInfo
- Publication number
- DK163238C DK163238C DK165684A DK165684A DK163238C DK 163238 C DK163238 C DK 163238C DK 165684 A DK165684 A DK 165684A DK 165684 A DK165684 A DK 165684A DK 163238 C DK163238 C DK 163238C
- Authority
- DK
- Denmark
- Prior art keywords
- tetrazol
- compounds
- quinolinon
- preparing
- procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/36—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Adhesives Or Adhesive Processes (AREA)
- Laminated Bodies (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/478,965 US4735948A (en) | 1983-03-25 | 1983-03-25 | (1H-tetrazol-5-yl)-2(1H)-quinolinones and-naphthyridones and antiallergic use thereof |
| US47896583 | 1983-03-25 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| DK165684D0 DK165684D0 (da) | 1984-03-23 |
| DK165684A DK165684A (da) | 1984-09-26 |
| DK163238B DK163238B (da) | 1992-02-10 |
| DK163238C true DK163238C (da) | 1992-06-29 |
Family
ID=23902120
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK165684A DK163238C (da) | 1983-03-25 | 1984-03-23 | 3-(1h-tetrazol-5-yl)-2(1h)-quinolinon samt farmaceutisk acceptable salte deraf og fremgangsmaade til fremstilling af disse forbindelser |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US4735948A (no) |
| EP (1) | EP0120483B1 (no) |
| JP (1) | JPS59176276A (no) |
| KR (1) | KR900003650B1 (no) |
| AT (1) | ATE26276T1 (no) |
| AU (1) | AU562115B2 (no) |
| CA (1) | CA1241001A (no) |
| DE (1) | DE3462895D1 (no) |
| DK (1) | DK163238C (no) |
| ES (1) | ES8601963A1 (no) |
| GR (1) | GR81908B (no) |
| IE (1) | IE57073B1 (no) |
| IL (1) | IL71319A (no) |
| NO (1) | NO841157L (no) |
| NZ (1) | NZ207581A (no) |
| PT (1) | PT78289B (no) |
| ZA (1) | ZA842065B (no) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT79031B (en) * | 1983-08-20 | 1986-08-22 | Boots Co Plc | Therapeutic agents |
| US5358949A (en) * | 1986-03-05 | 1994-10-25 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivatives and salts thereof and anti-arrhythmic agents containing the carbostyril derivatives |
| US4916131A (en) * | 1986-10-15 | 1990-04-10 | Schering Corporation | Naphthyridine derivatives and method for treating allergic reactions |
| EP0267691A3 (en) * | 1986-10-15 | 1989-08-23 | Schering Corporation | Use of 1-substituted naphthyridine and pyridopyrazine derivatives for the preparation of medicaments with immunosuppressor activity. |
| US5037826A (en) * | 1986-10-15 | 1991-08-06 | Schering Corporation | 1-substituted naphthyridine and pyridopyrazine derivatives |
| US5064837A (en) * | 1989-11-13 | 1991-11-12 | Schering Corporation | 3-substituted-1-aryl-2(h)-quinolones and their pharmaceutical compositions |
| GB9026389D0 (en) * | 1990-12-05 | 1991-01-23 | Merck Sharp & Dohme | Therapeutic agents |
| GB9125485D0 (en) * | 1991-11-29 | 1992-01-29 | Merck Sharp & Dohme | Therapeutic agents |
| US5658924A (en) * | 1992-12-01 | 1997-08-19 | The Green Cross Corporation | 1,8-naphthyridin-2-one derivative and use thereof |
| DE19727410A1 (de) * | 1997-06-27 | 1999-01-07 | Hoechst Schering Agrevo Gmbh | 3-(5-Tetrazolylcarbonyl)-2-chinolone und diese enthaltende nutzpflanzenschützende Mittel |
| GB0316546D0 (en) | 2003-07-15 | 2003-08-20 | Novartis Ag | Process for the manufacture of organic compounds |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1444369A (en) * | 1973-04-05 | 1976-07-28 | Allen & Hanburys Ltd | 1,8-naphthyridines |
| US3993656A (en) * | 1974-11-19 | 1976-11-23 | Merck & Co., Inc. | 1,8-Naphthyridine compounds |
| US4035368A (en) * | 1975-04-02 | 1977-07-12 | Riker Laboratories, Inc. | Substituted 3-(1H-tetrazol-5-yl)-quinoline compounds |
| US4350817A (en) * | 1980-02-28 | 1982-09-21 | American Home Products Corporation | 4-Cl, Br or I-3-Carboxy or cyano-1,2-dihydro-2-oxo-1,8-naphthyridine derivatives |
| NZ212209A (en) * | 1984-05-29 | 1988-08-30 | Pfizer | Quinolone derivatives and pharmaceutical compositions |
-
1983
- 1983-03-25 US US06/478,965 patent/US4735948A/en not_active Expired - Lifetime
-
1984
- 1984-03-20 CA CA000449959A patent/CA1241001A/en not_active Expired
- 1984-03-20 ZA ZA842065A patent/ZA842065B/xx unknown
- 1984-03-21 GR GR74164A patent/GR81908B/el unknown
- 1984-03-21 NZ NZ207581A patent/NZ207581A/en unknown
- 1984-03-21 PT PT78289A patent/PT78289B/pt not_active IP Right Cessation
- 1984-03-21 AU AU25952/84A patent/AU562115B2/en not_active Ceased
- 1984-03-22 JP JP59053691A patent/JPS59176276A/ja active Granted
- 1984-03-22 IL IL71319A patent/IL71319A/xx unknown
- 1984-03-22 ES ES530877A patent/ES8601963A1/es not_active Expired
- 1984-03-23 DE DE8484103231T patent/DE3462895D1/de not_active Expired
- 1984-03-23 DK DK165684A patent/DK163238C/da not_active IP Right Cessation
- 1984-03-23 IE IE720/84A patent/IE57073B1/en not_active IP Right Cessation
- 1984-03-23 EP EP84103231A patent/EP0120483B1/en not_active Expired
- 1984-03-23 NO NO841157A patent/NO841157L/no unknown
- 1984-03-23 AT AT84103231T patent/ATE26276T1/de active
- 1984-03-24 KR KR1019840001514A patent/KR900003650B1/ko not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA1241001A (en) | 1988-08-23 |
| IL71319A (en) | 1988-03-31 |
| DK165684D0 (da) | 1984-03-23 |
| KR840008153A (ko) | 1984-12-13 |
| JPS59176276A (ja) | 1984-10-05 |
| US4735948A (en) | 1988-04-05 |
| KR900003650B1 (ko) | 1990-05-28 |
| ES530877A0 (es) | 1985-11-01 |
| NZ207581A (en) | 1987-01-23 |
| ES8601963A1 (es) | 1985-11-01 |
| AU2595284A (en) | 1984-09-27 |
| EP0120483A1 (en) | 1984-10-03 |
| PT78289A (en) | 1984-04-01 |
| IE840720L (en) | 1984-09-25 |
| PT78289B (en) | 1986-04-22 |
| ATE26276T1 (de) | 1987-04-15 |
| EP0120483B1 (en) | 1987-04-01 |
| ZA842065B (en) | 1984-10-31 |
| IE57073B1 (en) | 1992-04-22 |
| JPH0452273B2 (no) | 1992-08-21 |
| DK165684A (da) | 1984-09-26 |
| IL71319A0 (en) | 1984-06-29 |
| AU562115B2 (en) | 1987-05-28 |
| DE3462895D1 (de) | 1987-05-07 |
| NO841157L (no) | 1984-09-26 |
| GR81908B (no) | 1984-12-12 |
| DK163238B (da) | 1992-02-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL189141C (nl) | Vulcaniseerbaar rubbermengsel en werkwijze voor het bereiden daarvan. | |
| DK397387A (da) | Carbostyrilderivater og salte deraf samt fremgangsmaade til fremstilling af saadanne forbindelser | |
| DK167187D0 (da) | Carbostyrilderivater og salte deraf, fremgangsmaade til fremstilling af saadanne forbindelser og laegemiddel indeholdende disse | |
| IT8004812A0 (it) | Procedimento per la riduzione di emissione di nox. | |
| NL8402946A (nl) | Antidepressieve 1,2,4-triazolon verbindingen; werkwijzen voor het bereiden daarvan; farmaceutische preparaten. | |
| DK163238C (da) | 3-(1h-tetrazol-5-yl)-2(1h)-quinolinon samt farmaceutisk acceptable salte deraf og fremgangsmaade til fremstilling af disse forbindelser | |
| NL7900455A (nl) | Nieuwe gesubstitueerde heterocyclische benzamiden, werkwijze voor de bereiding daarvan en toepassing als gedragsbeinvloedende stoffen. | |
| DK164155C (da) | Aminoguanidinderivater og farmaceutisk tolerable salte deraf, fremgangsmaade til fremstilling deraf, laegemidler indeholdende aminoguanidinderivater og fremgangsmaade til fremstilling af disse laegemidler | |
| NL187069C (nl) | N-acyl 3-(1-amino-3-methylbutyl)-8-hydroxy-3,4-dihydro-isocoumarine verbinding, werkwijze voor de bereiding daarvan en farmaceutisch preparaat. | |
| DK514182A (da) | Fremgangsmaade til fremstilling af n-substituerede 2-pyridylindoler eller n-oxider eller salte deraf | |
| FI821218A0 (fi) | Oxindolderivat, foerfarande foer deras framstaellning och dessa innehaollande laekemedel med neuroanabolisk verkan | |
| DK398483D0 (da) | Substiuerede tert.butanolderivater, fremgangsmader til fremstilling deraf samt antimykotiske midler indeholdende disse forbindelser | |
| ES530876A0 (es) | Un procedimiento para preparar (1h-tetrazol-5-il) tetrazolo (1, 5-a) quinolinas | |
| ES542208A0 (es) | Procedimiento para la obtencion de b-naftilalquilaminas | |
| DK564284A (da) | Pyrazinonderivater, fremgangsmaader til fremstilling deraf samt farmaceutiske midler indeholdende disse | |
| DK344277A (da) | Fremgangsmade til fremstilling af 2-oxa-7,9-diaza-bicyclo (4,2,2) decan-forbindelser og salte deraf | |
| DK475381A (da) | Fremgangsmaade til fremstilling af carboxamidforbindelser eller farmaceutisk acceptable salte deraf | |
| NL7611315A (nl) | Kleurontwikkelaar voor de werkwijze voor het kleuren-fotografische ontwikkelen. | |
| DK428483D0 (da) | Fremgangsmade til fremstilling af trisubstituerede diazaderivater eller farmaceutisk anvendelige salte deraf | |
| DK491383A (da) | 5-phenoxybenzoesyrederivater af pentiter, fremgangsmaade til fremstilling af disse forbindelser samt midler indeholdende disse forbindelser med herbicid virkning | |
| ATE29256T1 (de) | Oxazolyl substituierte diaza-heterozyklische verbindungen. | |
| DK152755C (da) | Fremgangsmaade til fremstilling af 3-substituerede tetrahydro-1,2,4-triaziner eller farmaceutisk acceptable salte heraf | |
| DK672289D0 (da) | Carbostyrilderivater og salte deraf, fremgangsmaade til fremstilling af saadanne forbindelser og laegemidler indeholdende disse |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PBP | Patent lapsed | ||
| PBP | Patent lapsed |